N-(3-((3-(Dimethylamino)propyl)amino)-1-(5-(3-nitrophenyl)furan-2-yl)-3-oxoprop-1-en-2-yl)-4-methylbenzamide

Catalog No. :
ACXHKY770
CAS No. :
324566-35-0
Molecular Formula :
C26H28N4O5
Molecular Weight :
476.53

IUPAC Name:(Z)-N-(3-((3-(dimethylamino)propyl)amino)-1-(5-(3-nitrophenyl)furan-2-yl)-3-oxoprop-1-en-2-yl)-4-methylbenzamide

N-(3-((3-(Dimethylamino)propyl)amino)-1-(5-(3-nitrophenyl)furan-2-yl)-3-oxoprop-1-en-2-yl)-4-methylbenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-((3-(Dimethylamino)propyl)amino)-1-(5-(3-nitrophenyl)furan-2-yl)-3-oxoprop-1-en-2-yl)-4-methylbenzamide
IUPAC Name(Z)-N-(3-((3-(dimethylamino)propyl)amino)-1-(5-(3-nitrophenyl)furan-2-yl)-3-oxoprop-1-en-2-yl)-4-methylbenzamide
Molecular FormulaC26H28N4O5
Molecular Weight476.53
SMILESO=C(N/C(C(NCCCN(C)C)=O)=C\C1=CC=C(C2=CC=CC([N+]([O-])=O)=C2)O1)C3=CC=C(C)C=C3
InChI KeyQFOLMPFZCVBCTJ-QJOMJCCJSA-N
SynonymN-[(Z)-3-[3-(dimethylamino)propylamino]-1-[5-(3-nitrophenyl)furan-2-yl]-3-oxoprop-1-en-2-yl]-4-methylbenzamide;Benzamide, N-[1-[[[3-(dimethylamino)propyl]amino]carbonyl]-2-[5-(3-nitrophenyl)-2-furanyl]ethenyl]-4-methyl-
CAS No.324566-35-0

Synthetic Route by SureRoute

1. ACXHKY770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUIJ862 route compound structure diagram
    ACEUIJ86252198-63-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXHKY770 route product structure diagram
    ACXHKY770324566-35-0
Inquiry

2. ACXHKY770 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXHKY770 route product structure diagram
    ACXHKY770324566-35-0
Inquiry

Comments (0)